Craft

Ondine

Total Funding

$807.9 K

Ondine Summary

Company Summary

Overview
Ondine Biomedical (formerly known as Ondine Biopharma Corporation) is a company specializing in non-antibiotic antimicrobial photo disinfection therapies. It creates a technology platform that destroys bacteria, viruses, yeasts and fungi, and associated virulence factors. Ondine's products include Steriwave nasal decolonization, Sinuwave, and SurgENT.
Type
Private
Status
Active
Founded
1997
Website
https://ondinebio.com/
Cybersecurity rating
Sectors

Table of Contents

Key People

  • Roger Andersen

    Roger Andersen, Vice President, Regulatory and Medical Affairs

    • Jason Hickok

      Jason Hickok, Vice President, Clinical and Medical Affairs

      Footer menu